Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2023 Jul;163(3):657-662.
doi: 10.1007/s11060-023-04381-9. Epub 2023 Jul 13.

CHD5 gene variant predicts leptomeningeal metastasis after surgical resection of brain metastases of breast cancer

Ryohei Otani  1 , Daichi Sadato  2 , Ryoji Yamada  3 , Hirohisa Yajima  3 , Shinji Kawamura  3 , Sakura Shimizu  3 , Shota Tanaka  4 , Shunsaku Takayanagi  4 , Hirokazu Takami  4 , Tatsuro Yamaguchi  5
Affiliations

CHD5 gene variant predicts leptomeningeal metastasis after surgical resection of brain metastases of breast cancer

Ryohei Otani et al. J Neurooncol. 2023 Jul.

Abstract

Purpose: Leptomeningeal metastasis (LM) is a complication of surgery for brain metastasis and is a risk factor of poor prognosis. The risk of LM is particularly high after surgery for a breast cancer metastasis to the brain. If the risk of LM after surgical resection for a brain metastasis were predictable, appropriate adjuvant therapy could be administered to individual patients to improve their prognosis. The present study aimed to reveal the genetic characteristics of brain metastases as means of predicting LM in breast cancer patients.

Methods: Ten patients with brain metastases of breast cancer presented LM after surgical resection were analyzed by whole-exome sequencing.

Results: A chromodomain-helicase-DNA-binding protein 5 (CHD5) gene alteration was detected in nine cases (90%), including a nonsynonymous variant in four cases and copy number deletion in five cases. CHD5 protein expression was lost in nine cases and had decreased in one case. The frequency of CHD5 gene alteration in brain metastases with LM was significantly higher than in primary breast cancer (2.3%) or in brain metastases of breast cancer (0%) (p < 0.0001).

Conclusions: These results suggested that the CHD5 gene alteration was associated with LM after surgical resection of breast cancer brain metastases. Searching for the gene alteration might predict the LM risk after surgical resection.

Keywords: Brain metastasis; Breast cancer; CHD5; Leptomeningeal metastasis; Prediction.

PubMed Disclaimer

Similar articles

See all similar articles

Cited by

References

    1. Le Rhun E, Weller M, Brandsma D, Van den Bent M, de Azambuja E, Henriksson R, Boulanger T, Peters S, Watts C, Wick W, Wesseling P, Ruda R, Preusser M, Board EE, Committee EG (2017) EANO-ESMO clinical practice guidelines for diagnosis, treatment and follow-up of patients with leptomeningeal metastasis from solid tumours. Ann Oncol 28:iv84–iv. https://doi.org/10.1093/annonc/mdx221 - DOI - PubMed
    1. Scott BJ, Oberheim-Bush NA, Kesari S (2016) Leptomeningeal metastasis in breast cancer - a systematic review. Oncotarget 7:3740–3747. https://doi.org/10.18632/oncotarget.5911 - DOI - PubMed
    1. Tewarie IA, Jessurun CAC, Hulsbergen AFC, Smith TR, Mekary RA, Broekman MLD (2021) Leptomeningeal disease in neurosurgical brain metastases patients: a systematic review and meta-analysis. Neurooncol Adv 3:vdab162. https://doi.org/10.1093/noajnl/vdab162 - DOI - PubMed - PMC
    1. Ilic I, Faron A, Heimann M, Potthoff AL, Schafer N, Bode C, Borger V, Eichhorn L, Giordano FA, Guresir E, Jacobs AH, Ko YD, Landsberg J, Lehmann F, Radbruch A, Herrlinger U, Vatter H, Schuss P, Schneider M (2021) Combined Assessment of Preoperative Frailty and Sarcopenia allows the prediction of overall survival in patients with Lung Cancer (NSCLC) and surgically treated Brain Metastasis. Cancers (Basel) 13. https://doi.org/10.3390/cancers13133353
    1. Prabhu RS, Turner BE, Asher AL, Marcrom SR, Fiveash JB, Foreman PM, Press RH, Patel KR, Curran WJ, Breen WG, Brown PD, Jethwa KR, Grills IS, Arden JD, Foster LM, Manning MA, Stern JD, Soltys SG, Burri SH (2019) A multi-institutional analysis of presentation and outcomes for leptomeningeal disease recurrence after surgical resection and radiosurgery for brain metastases. Neuro Oncol 21:1049–1059. https://doi.org/10.1093/neuonc/noz049 - DOI - PubMed - PMC

LinkOut - more resources